Jan. 4, 2019
AyuVis Research to Present at the Biotech Showcase™ Annual Conference on January 7, 2019
Fort Worth, Texas - AyuVis Research Inc., a company developing small molecule immune-modulating agents that enhance the body’s ability to fight inflammation and restore lung function, is scheduled to present at Biotech Showcase™ 2019 taking place January 7-9, 2018 at the Hilton San Francisco Union Square, San Francisco, CA.
The company was founded in 2014 by Suchismita (Suchi) Acharya, PhD, a medicinal pharmaceutical scientist and entrepreneur, and works with scientific experts in neonatology, pediatrics, pulmonology, inflammation and microbiology to advance its pharmaceutical programs to treat severe inflammatory diseases.
Details for the presentation:
Date: January 7, 2019
Time: 9:00 am PST
Room: Hilton/Franciscan C, Ballroom Level
Venue: Hilton San Francisco Union Square Hotel, 333 O’Farrell Street, San Francisco, CA
AyuVis Research, Inc. is a pre-clinical stage pharmaceutical company focused on the discovery and development of novel, multi-functional small molecules that boost the body’s natural ability to fight disorders associated with inflammation, immune modulation and microbial infection. Its lead candidate is in pre-clinical-IND enabling studies for the treatment of Bronchopulmonary dysplasia, a pediatric orphan indication of severe lung injury. It also has pre-clinical assets for Pseudomonas aeruginosa lung and skin infection and systemic inflammatory response syndrome.
For more information, visit www.ayuvis.com.